跳至主要内容
临床试验/IRCT20201121049452N1
IRCT20201121049452N1已完成3 期

Evaluation of the effect of the combination of Teriparatide and Calcium supplement in comparison with Calcium supplement alone on intertrochanteric fracture healing

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
All

入选标准

  • People over 50 years old with intertrochanteric fractures
  • use Triaparatide for a period of 3 months after surgery
  • Vitamin D with normal serum levels

排除标准

  • Teriparatide is prescribed before surgery
  • Teriparatide is prescribed for less than 3 months
  • Unacceptable fracture reduction
  • Multiple fractures
  • Underlying conditions, or self-medication that affects bone repai
  • Contralateral pelvic fractures
  • Pathological fractures
  • Any anti-osteoporosis medication (except calcium and vitamin d tablets)
  • Deficiencies in medical records

研究者

相似试验